Abstract
In an experimental system using rats, prepubertal treatment with cyclophosphamide was associated with slightly reduced fertility of the adult female. No malformations were noted in the offspring, and there was no change in the size of the rat pups produced. Reduction in litter size was apparent by day 11 of gestation, suggesting that losses before or around implantation were the most likely cause of the reduction in litter size.
The relevance of these results to cytotoxic drug therapy in the nephrotic syndrome in childhood is considered.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barratt T. M., Soothill J. F. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet. 1970 Sep 5;2(7671):479–482. doi: 10.1016/s0140-6736(70)90108-x. [DOI] [PubMed] [Google Scholar]
- Epstein S. S., Joshi S. R., Arnold E., Page E. C., Bishop Y. Abnormal zygote development in mice after paternal exposure to a chemical mutagen. Nature. 1970 Mar 28;225(5239):1260–1261. doi: 10.1038/2251260a0. [DOI] [PubMed] [Google Scholar]
- Gerlinger P. Contribution à l'étude de l'action tératogène du cyclophosphamide chez l'embryon de poulet et de lapin. Arch Anat Histol Embryol. 1966;49(1):247–317. [PubMed] [Google Scholar]
- Moncrieff M. W., White R. H., Oggs C. S., Cameron J. S. Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J. 1969 Mar 15;1(5645):666–671. doi: 10.1136/bmj.1.5645.666. [DOI] [PMC free article] [PubMed] [Google Scholar]